Filtration surgery rates drop

Article

The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.

The introduction of anti-glaucoma medications has reduced the need for filtration surgery, according to study results published online ahead of print by Eye.

P.A. Keane of the Department of Ophthalmology at Waterford Regional Hospital, Ireland and colleagues conducted a 20-year retrospective review of patients undergoing glaucoma filtration surgery (n=760) at Waterford Regional Hospital between January 1986 and December 2005.

Over the review period, three new anti-glaucoma medicines became available. The number of filtration surgeries performed fell annually: from 1986–1995, the mean annual figure was 23.75 per surgeon; by the 1998–2005 period, this had fallen to 12.69 procedures per surgeon per year. The age of patients undergoing surgery did not decrease across the review period.

The team concluded that, as the decrease in filtration surgeries was not correlated to patient age, the introduction of topical anti-glaucoma medication was the most likely cause for the reduction, although it remains unclear whether this is an absolute reduction or merely a delay in the need for surgery.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.